How Do We Identify and Manage Progressive CTD-ILD?-Update in Treatment and Guideline
The lung is a frequent target of autoimmune-mediated injury in patients with rheumatic diseases. Not infrequently, respiratory involvement may be the presenting manifestation of connective tissue diseases (CTDs). The prevalence of interstitial lung disease (ILD) in rheumatoid arthritis is about 20 t...
Saved in:
| Main Authors: | Oliver Distler, Toby Maher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2024-01-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341724740110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Efficacy of Quantitative Computed Tomography in CTD-ILA/ILD
by: Ke WANG, et al.
Published: (2025-07-01) -
Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01) -
Polydatin-curcumin formulation alleviates CTD-ILD-like lung injury in mice via GABBR/PI3K/AKT/TGF-β pathway
by: Zhengju Zhang, et al.
Published: (2025-06-01) -
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?
by: Francesco Amati, et al.
Published: (2025-06-01) -
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
by: Anna-Maria Hoffmann-Vold, et al.
Published: (2020-09-01)